Advertisement

Acoustic Schwannoma

  • William M. Mendenhall
  • Robert J. Amdur
  • Robert S. Malyapa
  • William A. Friedman

Abstract

Acoustic schwannomas are benign tumors that originate from Schwann cells surrounding the vestibular (eighth) nerve, usually within the internal auditory canal [1]. As the tumor enlarges, it fills the canal and extends into the cerebellopontine angle. Acoustic schwannomas are relatively uncommon with an incidence of approximately 1 new case per 100,000 [1]. The mean age at diagnosis is approximately 45 to 47 years, and there is a slight female preponderance [2].

Keywords

Facial Nerve Radiat Oncol Biol Phys Local Control Rate Vestibular Schwannoma Acoustic Neuroma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wiegand DA, Ojemann RG, Fickel V. Surgical treatment of acoustic neuroma (vestibular schwannoma) in the United States: report from the Acoustic Neuroma Registry. Laryngoscope 1996; 106:58–66.CrossRefPubMedGoogle Scholar
  2. 2.
    Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): Clinical presentation. Neurosurgery 1997; 40:1–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Abaza MM, Makariou E, Armstrong M, Lalwani AK. Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope 1996; 106:694–699.CrossRefPubMedGoogle Scholar
  4. 4.
    Friedman WA, Buatti JM, Bova FJ, Mendenhall WM. Linac Radiosurgery: A Practical Guide. New York: Springer-Verlag, 1998:1–176.Google Scholar
  5. 5.
    Szumacher E, Schwartz ML, Tsao M, et al. Fractionated stereotactic radiotherapy for the treatment of vestibular schwannomas: Combined experience of the Toronto-Sunnybrook Regional Cancer Centre and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 2002; 53:987–991.PubMedGoogle Scholar
  6. 6.
    Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy and radiosurgery for skull base tumors. Otolaryngol Clin North Am 2001; 34:1065–1077.CrossRefPubMedGoogle Scholar
  7. 7.
    Condra KS, Buatti JM, Mendenhall WM, et al. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997; 39:427–436.PubMedGoogle Scholar
  8. 8.
    Hinerman RW, Mendenhall WM, Amdur RJ, et al. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Head Neck 2001; 23:363–371.CrossRefPubMedGoogle Scholar
  9. 9.
    Parsons JT, McCarty PJ, Rao PV, et al. On the definition of local control (Editorial). Int J Radiat Oncol Biol Phys 1990; 18:705–706.PubMedGoogle Scholar
  10. 10.
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457–481.CrossRefGoogle Scholar
  11. 11.
    SAS Institute Inc. SAS OnlineDoc(r) version 9. Cary, NC: SAS Institute Inc., 2003.Google Scholar
  12. 12.
    Strasnick B, Glasscock ME III, Haynes D, et al. The natural history of untreated acoustic neuromas. Laryngoscope 1994; 104:1115–1119.CrossRefPubMedGoogle Scholar
  13. 13.
    Wiet RJ, Zappia JJ, Hecht CS, O’Connor CA. Conservative management of patients with small acoustic tumors. Laryngoscope 1995; 105:795–800.CrossRefPubMedGoogle Scholar
  14. 14.
    Deen HG, Ebersold MJ, Harner SG, et al. Conservative management of acoustic neuroma: an outcome study. Neurosurgery 1996; 39:260–266.CrossRefPubMedGoogle Scholar
  15. 15.
    Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope 2000; 110:497–508.CrossRefPubMedGoogle Scholar
  16. 16.
    Sakamoto T, Fukuda S, Inuyama Y. Hearing loss and growth rate of acoustic neuromas in follow-up observation policy. Auris Nasus Larynx 2001; 28:S23–S27.CrossRefPubMedGoogle Scholar
  17. 17.
    Arriaga MA, Carrier D, Houston GD. False-positive magnetic resonance imaging of small internal auditory canal tumors: a clinical, radiologic, and pathologic correlation study. Otolaryngol Head Neck Surg 1995; 113:61–70.CrossRefPubMedGoogle Scholar
  18. 18.
    Dandy WE. Results of removal of acoustic tumors by the unilateral approach. Arch Surg 1941; 42:1026–1033.Google Scholar
  19. 19.
    Harner SG, Beatty CW, Ebersold MJ. Retrosigmoid removal of acoustic neuroma: experience 1978–1988. Otolaryngol Head Neck Surg 1990; 103:40–45.PubMedGoogle Scholar
  20. 20.
    Rhoton AL Jr, Tedeschi H. Microsurgical anatomy of acoustic neuroma. Otolaryngol Clin North Am 1992; 25:257–294.PubMedGoogle Scholar
  21. 21.
    Roland PS, Meyerhoff WL, Wright CG, Mickey B. Anatomic considerations in the posterior approach to the internal auditory canal. Ann Otol Rhinol Laryngol 1988; 97:621–625.PubMedGoogle Scholar
  22. 22.
    Haberkamp TJ, Meyer GA, Fox M. Surgical exposure of the fundus of the internal auditory canal: Anatomic limits of the middle fossa versus the retrosigmoid transcanal approach. Laryngoscope 1998; 108:1190–1194.CrossRefPubMedGoogle Scholar
  23. 23.
    Shelton C, Hitselberger WE, House WF, Brackmann DE. Hearing preservation after acoustic tumor removal: Long-term results. Laryngoscope 1990; 100:115–119.PubMedGoogle Scholar
  24. 24.
    Welling DB, Slater PW, Thomas RD, et al. The learning curve in vestibular schwannoma surgery. Am J Otolaryngol 1999; 20:644–648.Google Scholar
  25. 25.
    Wiet RJ, Mamikoglu B, Odom L, Hoistad DL. Long-term results of the first 500 cases of acoustic neuroma surgery. Otolaryngol Head Neck Surg 2001; 124:645–651.CrossRefPubMedGoogle Scholar
  26. 26.
    Wackym PA, King WA, Poe DS, et al. Adjunctive use of endoscopy during acoustic neuroma surgery. Laryngoscope 1999; 109:1193–1201.CrossRefPubMedGoogle Scholar
  27. 27.
    Morikawa M, Tamaki N, Nagashima T, Motooka Y. Long-term results of facial nerve function after acoustic neuroma surgery-clinical benefit of intraoperative facial nerve monitoring. Kobe J Med Sci 2000; 46:113–124.PubMedGoogle Scholar
  28. 28.
    Sterkers JM, Morrison GA, Sterkers O, El-Dine MM. Preservation of facial, cochlear, and other nerve functions in acoustic neuroma treatment. Otolaryngol Head Neck Surg 1994; 110:146–155.PubMedGoogle Scholar
  29. 29.
    Gormley WB, Sekhar LN, Wright DC, et al. Acoustic neuromas: results of current surgical management. Neurosurgery 1997; 41:50–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Gjuric M, Wigand ME, Wolf SR. Enlarged middle fossa vestibular schwannoma surgery: experience with 735 cases. Otol Neurotol 2001; 22:223–230.CrossRefPubMedGoogle Scholar
  31. 31.
    Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): Surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 1997; 40:11–23.CrossRefPubMedGoogle Scholar
  32. 32.
    Buchman CA, Chen DA, Flannagan P, et al. The learning curve for acoustic tumor surgery. Laryngoscope 1996; 106:1406–1411.CrossRefPubMedGoogle Scholar
  33. 33.
    Kaylie DM, Gilbert E, Horgan MA, et al. Acoustic neuroma surgery outcomes. Otol Neurotol 2001; 22:686–689.CrossRefPubMedGoogle Scholar
  34. 34.
    Hecht CS, Honrubia VF, Wiet RJ, Sims HS. Hearing preservation after acoustic neuroma resection with tumor size used as a clinical prognosticator. Laryngoscope 1997; 107:1122–1126.CrossRefPubMedGoogle Scholar
  35. 35.
    Shirato H, Sakamoto T, Takeichi N, et al. Fractionated stereotactic radiotherapy for vestibular schwannona (VS): comparison between cystic-type and solid-type VS. Int J Radiat Oncol Biol Phys 2000; 48:1395–1401.CrossRefPubMedGoogle Scholar
  36. 36.
    Fuss M, Debus J, Lohr F, et al. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 2000; 48:1381–1387.CrossRefPubMedGoogle Scholar
  37. 37.
    Andrews DW, Suarez O, Goldman HW, et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001; 50:1265–1278.PubMedGoogle Scholar
  38. 38.
    Bush DA, Mcallister CJ, Loredo LN, et al. Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery 2002; 50:270–275.CrossRefPubMedGoogle Scholar
  39. 39.
    Sakamoto T, Shirato H, Takeichi N, et al. Annual rate of hearing loss falls after fractionated stereotactic irradiation for vestibular schwannoma. Radiother Oncol 2001; 60:45–48.CrossRefPubMedGoogle Scholar
  40. 40.
    Sakamoto T, Shirato H, Takeichi N, et al. Medication for hearing loss after fractionated stereotactic radiotherapy (SRT) for vestibular schwannoma. Int J Radiat Oncol Biol Phys 2001; 50:1295–1298.PubMedGoogle Scholar
  41. 41.
    Kaylie DM, Horgan MJ, Delashaw JB, McMenomey SO. A metaanalysis comparing outcomes of microsurgery and gamma knife radiosurgery. Laryngoscope 2000; 110:1850–1856.CrossRefPubMedGoogle Scholar
  42. 42.
    Myrseth E, Moller P, Pedersen PH, et al. Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery 2005; 56:927–935.PubMedGoogle Scholar
  43. 43.
    Friedman WA, Bradshaw P, Myers A, Bova FJ. Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg 2006; 105:657–661.CrossRefPubMedGoogle Scholar
  44. 44.
    Hasegawa T, Fujitani S, Katsumata S, et al. Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery 2005; 57:257–265.CrossRefPubMedGoogle Scholar
  45. 45.
    Weber DC, Chan AW, Bussiere MR, et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery 2003; 53:577–586.CrossRefPubMedGoogle Scholar
  46. 46.
    Lunsford LD, Niranjan A, Flickinger JC, et al. Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 2005; 102(Suppl):195–199.CrossRefPubMedGoogle Scholar
  47. 47.
    Flickinger JC, Kondziolka D, Niranjan A, et al. Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 2004; 60:225–230.CrossRefPubMedGoogle Scholar
  48. 48.
    Noren G, Greitz D, Hirsch A, Lax I. Gamma knife surgery in acoustic tumors. Acta Neurochir Suppl (Wien) 1993; 58:104–107.Google Scholar
  49. 49.
    Massager N, Nissim O, Delbrouck C, et al. Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery. Int J Radiat Oncol Biol Phys 2006; 64:1331–1340.PubMedGoogle Scholar
  50. 50.
    Foote KD, Friedman WA, Buatti JM, et al. Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 2001; 95:440–449.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • William M. Mendenhall
    • 1
  • Robert J. Amdur
    • 2
  • Robert S. Malyapa
    • 3
  • William A. Friedman
    • 4
  1. 1.Department of Radiation OncologyUniversity of Florida College of MedicineGainesvilleUSA
  2. 2.University of Florida College of MedicineGainesvilleUSA
  3. 3.Department of Radiation OncologyUniversity of Florida College of MedicineJacksonvilleUSA
  4. 4.Department of NeurosurgeryUniversity of Florida College of MedicineGainesvilleUSA

Personalised recommendations